March 30
Transcription
Dugat Among "40 Under 40: Professors Who Inspire" Phi Zeta Research Day Thursday, April 2, is the 19th Annual Phi Zeta Research Day. All are welcome to the presentations that will be held simultaneously in Room 104 at the Veterinary Medical Hospital and in McElroy Hall Auditorium. The morning session runs from 8:45 a.m. to 11 a.m. and the afternoon session runs from 1 p.m. to 5 p.m. The keynote address will feature Dr. Ted Mashima, associate executive director for academic and research affairs at the Association of American Veterinary Medical Colleges. He will present " Excellence in Science Requires Excellent Research Plus..." at 11 a.m. in the auditorium. If you are unable to attend in person, this presentation will be streamed live at http://www.ostate.tv/. Congratulations to Danielle Dugat, DVM, DACVS, on being selected as a "40 Under 40: Professors Who Inspire!" Dr. Dugat is an assistant professor of small animal surgery at the Veterinary Medical Hospital. Read more here: http://goo.gl/X4vtBd. Congratulations to Three Alumni Congratulations to Drs. Shem Oliver ('10), Zach Ricker ('05) and J.T. Walker ('04) on becoming board certified in veterinary surgery. All three recently passed the certifying examination to become Diplomates of the American College of Veterinary Surgeons. Oliver is working at Performance Equine Associates in Thackerville, Okla. Ricker is working at Oklahoma Veterinary Specialists in Tulsa, Okla., and Walker is a lecturer in Small Animal Surgery at the CVHS. If you know of other OSU alumni who are making their alma mater proud, please let us know so we can brag on your success! Special thanks to this year's sponsors Zoetis, Royal Canin, CVHS, CVHS-Academic Affairs, and CVHS-Research and Graduate Education. The Nu Chapter of Phi Zeta will host the 19th Annual Banquet at Meditations beginning at 6 p.m. Veterinary Voices Seminar Mark your calendar to attend the next Veterinary Voices Seminar featuring Dr. Dan Burba. Burba will present "Navicular Syndrome and Your Horse" on Tuesday, April 7, at 7 p.m. in McElroy Hall Auditorium (full story http://goo.gl/o3ReY4). If you cannot attend the seminar, it will be streamed live at www.ostate.tv. OSU/OVMA Summer Seminar Registration is now open for the 2015 OSU/OVMA Summer Seminar to be held June 12 and 13. Companion animal, equine, food animal and general sessions will be available. A Companion Animal Cytology Wet Lab will be offered to the first 15 registrants featuring Theresa Rizzi, DVM, DACVP, Department of Veterinary Pathobiology. For more information visit http://goo.gl/iLPJiI.
Similar documents
Global Veterinary Diagnostics Market Size, Share, Development, Growth and Demand Forecast to 2020
The global veterinary diagnostics market is growing significantly due rising requirement for combat antimicrobial-resistant bacteria, increasing awareness of animal health in emerging economies, and growing investment in developing economies in the industry. Increasing number of new and technologically advanced products in veterinary diagnostics market is creating sufficient opportunity for the veterinary diagnostics market to grow at a substantial rate in the forecasted period. In addition, massive unexplored market in veterinary diagnostics industry of developing economies are creating ample opportunities for the veterinary diagnostics market to grow at a considerable rate in the coming years.
More informationFlavoured Veterinary Medications Market - Segments, Dynamics, Size and Forecast (2015 - 2021)
Recently, Elanco Animal Health announced that the Interceptor Flavor Tablets (milbemycin oxime) would be back in the veterinary market. Interceptor Flavor Tablets protects against whipworms, roundworms and hookworms in dogs. They also prevent heartworms diseases in cats and kittens. Merck Animal Health announced the approval of BRAVECTO™ (four-lane) chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). It quickly and effectively kills fleas and multiple tick species for 12 weeks in a single dose. Virbac Corporation announced an agreement with Eli Lilly and Company to acquire major U.S. veterinary products currently marketed by Novartis Animal Health.
More information